Activation of natural killer cells with interleukin 2 (IL‐2) and IL‐12 increases perforin binding and subsequent lysis of tumour cells

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Haematology

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.2001.02995.xPMID 11552995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.

  2000cited by this paper
• Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.

  1999cited by this paper
• Perforin is a major contributor to NK cell control of tumor metastasis.

  1999cited by this paper
• Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity

  1999cited by this paper
• How do cytotoxic lymphocytes kill their targets?

  1998cited by this paper
• Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.

  1998cited by this paper
• Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity.

  1997cited by this paper
• The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent

  1997cited by this paper
• Nonsecretory apoptotic killing by human NK cells.

  1996cited by this paper
• T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.

  1996cited by this paper
• T Cells, Graft-versus-Host Disease and Graft-versus-Leukemia: Innovative Approaches for Blood and Marrow Transplantation

  1996cited by this paper
• High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.

  1996cited by this paper
• Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.

  1996influential reference
• Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?

  1996cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• The CTL's kiss of death.

  1995cited by this paper
• NK‐lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.

  1995cited by this paper
• Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules.

  1994cited by this paper
• Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.

  1993cited by this paper
• A natural killer cell granule protein that induces DNA fragmentation and apoptosis

  1992cited by this paper
• Resistance of cytolytic lymphocytes to perforin-mediated killing. Inhibition of perforin binding activity by surface membrane proteins.

  1990influential reference
• Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte☆

  1990cited by this paper
• Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte.

  1990cited by this paper
• Perforin binding to cells and lipid membranes determined by a simple competition assay.

  1990influential reference
• Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.

  1990cited by this paper
• Purified perforin induces target cell lysis but not DNA fragmentation

  1989cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper
• Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity

  1986cited by this paper

• Advances in chimeric antigen receptor-natural killer cell therapy: from mechanisms and preclinical studies to clinical application

  2026cites this paper
• Nanomaterial-Interleukin Combination for Boosting NK Cell-Based Tumor Immunotherapy.

  2025cites this paper
• Therapeutic approaches to enhance natural killer cell cytotoxicity

  2024cites this paper
• N6-methyladenosine and its epitranscriptomic effects on hematopoietic stem cell regulation and leukemogenesis

  2024cites this paper
• Natural killer cell-based therapies in neuroblastoma.

  2024cites this paper
• Novel insights into immune cells modulation of tumor resistance.

  2024cites this paper
• Use of a platform with lens-free shadow imaging technology to monitor natural killer cell activity.

  2024cites this paper
• Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics

  2023cites this paper
• Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges

  2023cites this paper
• Cellular immunity analysis by a modular acoustofluidic platform: CIAMAP

  2023cites this paper
• Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer.

  2023cites this paper
• Cancer immunotherapies: A hope for the uncurable?

  2023cites this paper
• Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential

  2022cites this paper
• Engineering IL-2 for immunotherapy of autoimmunity and cancer

  2022cites this paper
• Monalizumab e�cacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines

  2022cites this paper
• Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines

  2022cites this paper
• Determining Optimal Combination Regimens for Patients with Multiple Myeloma.

  2022cites this paper
• SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.

  2022cites this paper
• Single cell profiling reveals functional heterogeneity and serial killing in human peripheral and ex vivo-generated CD34+ progenitor derived Natural Killer cells

  2022cites this paper
• NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells

  2021cites this paper
• NF-kB c-Rel is dispensable for the development but is required for the cytotoxic function of NK cells

  2021cites this paper
• Structural basis for IL-12 and IL-23 shared receptor usage reveals a gateway for shaping actions on T versus NK cells

  2021cites this paper
• Resveratrol Enhances the Cytotoxic Activity of Lymphocytes from Menopausal Women

  2021cites this paper
• Implications of a ‘Third Signal’ in NK Cells

  2021cites this paper
• Cell–cell interactions via non-covalent click chemistry†

  2021cites this paper
• IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella

  2021cites this paper
• Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.

  2021cites this paper
• Validation of an Image-Based 3D Natural Killer Cell-Mediated Cytotoxicity Assay

  2020cites this paper
• Fenntartó kezelési módok felnőttkori rosszindulatú hematológiai betegségekben

  2020cites this paper
• Maintenance therapy in malignant oncohematology, recent advances, evolving concepts

  2020cites this paper
• Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies

  2020cites this paper
• Metformin and cancer immunity

  2020cites this paper
• Increased IL-2 and Reduced TGF-β Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis

  2020cites this paper
• Sialylation of Human Natural Killer (NK) Cells Is Regulated by IL-2

  2020cites this paper
• Overcoming hypoxia-induced functional suppression of NK cells

  2020cites this paper
• HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

  2020cites this paper
• Effects of Exercise on the Tumour Microenvironment.

  2020cites this paper
• Recombinant human thrombopoietin combined with interleukin-2 improves the effects of chemosensitivity and thrombocytopenia on a basic gemcitabine and carboplatin combination therapy for non-small cell lung cancer in a nude mouse model.

  2019cites this paper
• The rise of human stem cell-derived natural killer cells for cancer immunotherapy

  2019cites this paper
• IL‐21 reinvigorates exhausted natural killer cells in patients with HBV‐associated hepatocellular carcinoma in STAT1‐depedent pathway

  2019cites this paper
• Combination Immunotherapy with Inhibitor of Apoptosis (IAP) Antagonists to Treat Neuroblastoma

  2019cites this paper
• A single centre, parallel group pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling

  2019cites this paper
• Immunomodulatory actions and epigenetic alterations induced by proteases from Bothrops snake venoms in human immune cells.

  2019cites this paper
• Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer

  2019cites this paper
• Maintenance therapy in AML: The past, the present and the future

  2019cites this paper
• An inherent T cell deficit in healthy males to C. neoformans infection may begin to explain the sex susceptibility in incidence of cryptococcosis

  2019cites this paper
• Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients

  2019cites this paper
• Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy

  2019cites this paper
• First Insights in NK—DC Cross-Talk and the Importance of Soluble Factors During Infection With Aspergillus fumigatus

  2018cites this paper
• A Mathematical Model for Tumor–Immune Dynamics in Multiple Myeloma

  2018cites this paper
• Mesenchymal stem cells therapy protects fetuses from resorption and induces Th2 type cytokines profile in abortion prone mouse model.

  2018cites this paper
• The systemic immune response to pediatric thermal injury.

  2018cites this paper
• Enhanced perforin expression associated with dasatinib therapy in natural killer cells.

  2018cites this paper
• Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy

  2018cites this paper
• Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma.

  2018cites this paper
• Redundant and regulatory roles for Toll‐like receptors in Leishmania infection

  2017cites this paper
• Herstellung und Charakterisierung von CD13-spezifischen Antikörperderivaten für die diagnostische und therapeutische Anwendung bei hämatologischen und soliden Krebserkrankungen

  2017cites this paper
• Immunomodulatory and neuroprotective approaches including human mesenchymal precursor cell transplantation for spinal cord injury repair

  2017cites this paper
• Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells

  2016cites this paper
• Emerging cytokine networks in osteosarcoma

  2016cites this paper
• Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients

  2016cites this paper
• Assessment of combined vaccination and immune modulation as an anti-tumour therapy

  2016cites this paper
• IL-12 Restores Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients

  2015cites this paper
• Effects of Active Hexose Correlated Compound on the Seasonal Variations of Immune Competence in Healthy Subjects

  2015cites this paper
• Antitumor activities of ginseng polysaccharide in C57BL/6 mice with Lewis lung carcinoma

  2014influential citation
• Healthy Subjects Effects of Active Hexose Correlated Compound on the Seasonal Variations of Immune Competence in

  2014cites this paper
• HKBU Institutional Repository

  2014cites this paper
• Prophylactic and Therapeutic Modulation of Innate and Adaptive Immunity Against Mucosal Infection of Herpes Simplex Virus

  2014cites this paper
• Exploring alternative cytotoxic strategies for cancer treatment

  2014influential citation
• Immunsystemets dobbeltrolle i kreftutvikling

  2013cites this paper
• Manipulating the immune response of Tasmanian Devils to target Devil Facial Tumour Disease

  2013cites this paper
• HEPATITIS C VIRUS IMPAIRS NATURAL KILLER CELL MEDIATED

  2013cites this paper
• Type I Interferon Activation of Natural Killer (NK) Cells by Cytomegalovirus (CMV) and Their Interaction with Dendritic (DC) and NKT Cells

  2013cites this paper
• Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity.

  2013cites this paper
• Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis

  2013cites this paper
• Mechanisms underlying innate immunesenescence

  2013cites this paper
• Generation of Natural Killer Cells from Umbilical Cord Blood Stem Cells, Characterisation and Application for Immunotherapy

  2013cites this paper
• Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells.

  2012cites this paper
• Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications

  2012cites this paper
• Cytokine Is Not the Ortholog of Mouse Ym1 Erroneously Known as Eosinophil Chemotactic Human Acidic Mammalian Chitinase

  2011cites this paper
• TL1A Selectively Enhances IL-12/IL-18-Induced NK Cell Cytotoxicity against NK-Resistant Tumor Targets

  2010cites this paper
• Perforin: More than Just a Pore-Forming Protein

  2010cites this paper
• Effect of immunostimulation by detoxified E. coli lipopolysaccharide combined with inactivated Propionibacterium granulosum cells on porcine immunity.

  2009cites this paper
• The effect of human cytomegalovirus on innate immune responses : Immune activation and evasion

  2009cites this paper
• Cryptococcus neoformans Directly Stimulates Perforin Production and Rearms NK Cells for Enhanced Anticryptococcal Microbicidal Activity

  2009cites this paper
• Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15.

  2008cites this paper
• Investigating the potential of the Metastasis Associated Antigen 1 (MTA1) for cancer immunotherapy in a murine model

  2007influential citation
• Natural Killer Cells for the Treatment of Malignancies*

  2006cites this paper
• Analyses and perspectives in cancer immunotherapy.

  2006cites this paper
• NK Lytic-Associated Molecule, Involved in NK Cytotoxic Function, Is an E3 Ligase1

  2006cites this paper
• Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy

  2006cites this paper
• Regulatory mechanisms and their therapeutic implications of interleukin-12 production in immune cells.

  2005cites this paper
• Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.

  2005cites this paper
• Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages

  2005cites this paper
• Lymphocytic on Leukemic B Cells in Chronic Effect of CD3/CD28 Bead-Activated T Cells

  2005cites this paper
• Importance of stromal determinants in the generation of dendritic and natural killer cells in the human spleen

  2005cites this paper
• Leukemia Lymphocyticon Leukemic B Cells in Chronic Effect of CD 3 / CD 28 Bead-Activated T Cells

  2005cites this paper
• APC-Independent NK Cell Activation

  2005cites this paper
• Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses

  2004cites this paper
• NK cells: innate immunity against hematological malignancies?

  2004cites this paper